Technology | December 30, 2013

Tool helps take subjectivity out of breast density assessment

mammography systems women's healthcare vucomp m-vu breast density

December 30, 2013 — VuComp Inc. introduced M-Vu Breast Density, a tool for radiologists that provides automated assessment of breast density from a digital mammogram.
 
Clinical studies have shown that extensive breast density can make breast cancer detection in a mammogram more difficult and may also be associated with a higher cancer risk. Because of these issues, radiologists classify breast density using a four-level density scale established by the American College of Radiology (ACR) as part of its Breast Imaging Reporting and Data System (BI-RADS) standard. Patients who fall into one of the higher density categories may be recommended for additional screening exams. Legislation has been passed in 13 states requiring physicians to notify patients if their breast density is in one of the two higher categories.
 
VuComp’s M-Vu Breast Density uses computer vision algorithms to evaluate the appearance of structures and textures in the breast to differentiate between fatty and dense regions. The algorithms then calculate a percentage of breast area that is dense and convert it to one of four density categories corresponding to the BI-RADS standard.
 
“In contrast to the volumetric approach, we designed M-Vu Breast Density to analyze the appearance of fibroglandular tissue rather than simply the total amount of such tissue, in order to better help doctors assess the risk that a cancer may be hidden in a mammogram,” said Jeff Wehnes, president and CEO, VuComp.
 
M-Vu Breast Density is immediately available. It can be combined with VuComp’s computer-aided detection system, M-Vu CAD, to provide a set of analysis tools for mammography.
 
For more information: www.vucomp.com

Related Content

News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now